
New pathway facilitates community college students joining UC Riverside medical school
The School of Medicine at the University of California, Riverside, has received a grant of $1.87 million to establish the Inland Empire Regional Hub for Healthcare Opportunity, or IE RHHO, which will create a pre-med pathway for local community college students. The four-year grant funding is provided by the California...

Riverside clinic to address healthcare needs of the homeless
UniHealth Foundation grant to UC Riverside aims to increase the health and well-being of the unhoused population in Riverside County

Marginalized communities of color face high COVID-19 risk
UC Riverside study focused on farm-working communities in California’s Eastern Coachella Valley

Is there still a benefit to masking?
UC Riverside epidemiologist weighs in on how protective your mask is when nobody around you is masked

UCR biomedical scientist joins international SARS-CoV-2 group assembled by NIAID
SAVE focuses on mutations in SARS-CoV-2 and emerging virus variants

Should you get a second booster shot for COVID-19?
UC Riverside’s Dr. David Lo, a vaccine expert, shares his thoughts

A potential antiviral for SARS and SARS-like coronaviruses
UC Riverside-led study shows how an effective therapy against SARS-CoV-2 could be developed

Scientists profile FDA-approved drugs to potentially treat hundreds of genetic disorders
New method developed by UC Riverside researchers quickly assesses drug potential for rare disorders

Researchers develop molecular traps to target SARS-CoV-2
Joint effort by UC Riverside and UCLA scientists aims to stop the COVID-19-spreading virus from attacking immune cells

Scientists discover new avian immunological pathway
UC Riverside-led team identifies a new host protein interaction that produces a robust immune response to viral infection in birds and may lead to better poultry vaccines

Is it time to wear a highly efficient medical grade facemask?
UC Riverside experts weigh in

A more targeted therapy to treat inflammatory bowel disease
UC Riverside mouse study focuses on the receptor TNFR1